Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$52.42

-5.25 (-9.10%)

07:48
11/30/16
11/30
07:48
11/30/16
07:48

Mallinckrodt price target lowered to $70 from $92 at Leerink

Leerink analyst Jason Gerberry lowered his price target for Mallinckrodt to $70 from $92 following quarterly results due to a lack of near-term catalysts. The analyst reiterates an Outperform rating on the shares.

  • 30

    Nov

  • 02

    Dec

  • 14

    Dec

MNK Mallinckrodt
$52.42

-5.25 (-9.10%)

11/17/16
WELS
11/17/16
NO CHANGE
WELS
Outperform
Mallinckrodt drop on short-seller report a buying opportunity, says Wells Fargo
Wells Fargo analyst David Maris said the 12% drop in Mallinckrodt on the heels of a new report from short-seller Citron Research presents a buying opportunity, as he believes the assertion that Acthar has no clinical data is incorrect. Maris noted the report came out during Mallinckrodt's quiet period, which is something that had previously happened with a prior Citron report on the company, but the company tells him that the CEO's previous answer to a question regarding Acthar's exposure to Medicaid and Medicare was accurate. Maris keeps an Outperform rating on Mallinckrodt shares.
11/17/16
RAJA
11/17/16
INITIATION
Target $72
RAJA
Outperform
Mallinckrodt initiated with an Outperform at Raymond James
Raymond James initiated Mallinckrodt with an Outperform and a $72 price target.
11/18/16
RAJA
11/18/16
INITIATION
Target $72
RAJA
Outperform
Mallinckrodt initiated with an Outperform and $72 price target at Raymond James
Raymond James analyst Elliot WIlbur initiated Mallinckrodt with an Outperform and a $72 price target saying negative sector sentiment combined with further allegations from short sellers have created a compelling entry point. Wilbur believes Mallinckrodt provides one of the most sustainable top and bottom line growth trajectories in specialty pharmaceuticals and notes Achar has only a 3% penetration rate of the total addressable market, giving it a long runway of growth.
11/21/16
UBSW
11/21/16
NO CHANGE
Target $92
UBSW
Buy
Mallinckrodt weakness does not make sense, says UBS
UBS analyst Marc Goodman attended Mallinckrodt investors meetings and came away believing investors misunderstand the company story. The analyst said the company's Acthar drug, which has come under fire, has little relevance to the overall story. Goodman said the company has focused on enhancing clinical and health-economics data to help support better coverage and it is working. He said its emerging pipeline is under-appreciated. Goodman reiterated his Buy rating and $92 price target on Mallinckrodt shares.

TODAY'S FREE FLY STORIES

ITUB

Itau Unibanco

$13.27

0.03 (0.23%)

15:20
11/22/17
11/22
15:20
11/22/17
15:20
Options
Opening interest in Itau Unibanco upside calls »

Opening interest in Itau…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
11/22/17
11/22
15:17
11/22/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
11/22/17
11/22
15:16
11/22/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRX

Valeant

$16.68

0.685 (4.28%)

15:10
11/22/17
11/22
15:10
11/22/17
15:10
Options
$2M DOOM puts opened in Valeant tied to hedge »

$2M DOOM puts opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Jun

FTR

Frontier Communications

$7.08

-0.15 (-2.07%)

15:05
11/22/17
11/22
15:05
11/22/17
15:05
Options
Frontier Communications call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
11/22/17
11/22
15:00
11/22/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

14:55
11/22/17
11/22
14:55
11/22/17
14:55
General news
FX Action: The dollar faded further »

FX Action: The dollar…

MCD

McDonald's

$169.13

0.8301 (0.49%)

14:53
11/22/17
11/22
14:53
11/22/17
14:53
Periodicals
McDonald's temporarily pulling chicken tenders due to high demand, BI reports »

McDonald's, unable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLM

Sallie Mae

$10.60

-0.03 (-0.28%)

14:50
11/22/17
11/22
14:50
11/22/17
14:50
Options
SLM sees bullish option flow »

SLM sees bullish option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQM

SQM

$56.50

-0.835 (-1.46%)

14:49
11/22/17
11/22
14:49
11/22/17
14:49
Options
SQM options imply 5.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

, WMT

Wal-Mart

$96.39

-0.13 (-0.13%)

14:42
11/22/17
11/22
14:42
11/22/17
14:42
Periodicals
Online shopping already set new record, CNBC reports »

With Black Friday and…

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

WMT

Wal-Mart

$96.39

-0.13 (-0.13%)

BBY

Best Buy

$56.72

0.66 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    Mar

TRP

TransCanada

$49.68

-0.58 (-1.15%)

14:33
11/22/17
11/22
14:33
11/22/17
14:33
Conference/Events
TransCanada to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$66.68

0.95 (1.45%)

, AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

14:26
11/22/17
11/22
14:26
11/22/17
14:26
Recommendations
Cerner, Amazon.com analyst commentary  »

Cerner/AWS partnership…

CERN

Cerner

$66.68

0.95 (1.45%)

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 18

    Mar

14:25
11/22/17
11/22
14:25
11/22/17
14:25
General news
FOMC minutes showed concerns over low inflation »

FOMC minutes showed…

OTEX

OpenText

$33.91

0.38 (1.13%)

14:23
11/22/17
11/22
14:23
11/22/17
14:23
Hot Stocks
Battleground: Macquarie says sell OpenText, Raymond James remains bullish »

This morning, Macquarie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FEIM

Frequency Electronics

$9.32

-0.11 (-1.17%)

14:22
11/22/17
11/22
14:22
11/22/17
14:22
Hot Stocks
Frequency Electronics appoints largest shareholder to its board »

Frequency Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
11/22/17
11/22
14:20
11/22/17
14:20
General news
Treasury Action: yields remained at low ebb »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

14:17
11/22/17
11/22
14:17
11/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
11/22/17
11/22
14:16
11/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

$38.98

0.04 (0.10%)

, WFBI

WashingtonFirst

$33.70

-0.13 (-0.38%)

14:12
11/22/17
11/22
14:12
11/22/17
14:12
Hot Stocks
Sandy Spring Bancorp reports receipt of all regulatory approvals for acquisition »

Sandy Spring Bancorp…

SASR

Sandy Spring Bancorp

$38.98

0.04 (0.10%)

WFBI

WashingtonFirst

$33.70

-0.13 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

ILG

ILG

$28.11

-0.5 (-1.75%)

14:10
11/22/17
11/22
14:10
11/22/17
14:10
Options
Repeat option activity in ILG »

Repeat option activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

  • 01

    Dec

14:06
11/22/17
11/22
14:06
11/22/17
14:06
General news
Fed staff still see 'moderate' vulnerabilities in U.S. financial system »

The minutes from the…

14:02
11/22/17
11/22
14:02
11/22/17
14:02
General news
Fed minutes show 'many' saw 'near term' rate hike as warranted »

The minutes from the…

JACK

Jack in the Box

$102.57

-0.41 (-0.40%)

, APO

Apollo Global

$30.53

0.37 (1.23%)

13:59
11/22/17
11/22
13:59
11/22/17
13:59
Periodicals
Apollo near deal to buy Qdoba for over $300M, Reuters says »

Private equity firm…

JACK

Jack in the Box

$102.57

-0.41 (-0.40%)

APO

Apollo Global

$30.53

0.37 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

SASR

Sandy Spring Bancorp

$38.98

0.04 (0.10%)

, WFBI

WashingtonFirst

$33.70

-0.13 (-0.38%)

13:52
11/22/17
11/22
13:52
11/22/17
13:52
Hot Stocks
Federal Reserve Board approves merger of Sandy Spring Bancorp, WashingtonFirst »

The Federal Reserve Board…

SASR

Sandy Spring Bancorp

$38.98

0.04 (0.10%)

WFBI

WashingtonFirst

$33.70

-0.13 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.